(Alliance News) - Stock prices in London were predominantly lower at midday on Wednesday, though the FTSE 100 continued in the green, thanks to its exposure to the oil and defence sectors. Read More
(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their cancer drug Enhertu received a priority review by the Food & Drug Administration in the US for some forms of breast cancer. Read More
(Alliance News) - Stock prices in London opened a mixed bag in London on Tuesday, with the FTSE 100 in the green, but compatriot indices in the red, ahead of a slew of manufacturing PMIs later in the day. Read More
(Alliance News) - Stocks opened higher in London on Tuesday morning, after data showed that UK shop prices have moved further into deflation. Read More
(Alliance News) - Stock prices in London were still in the green at midday on Thursday, during a week in which China has been "the talk of the town". Read More
(Alliance News) - AstraZeneca PLC on Thursday said that its cancer drug Tagrisso has been approved in the US for certain type of lung cancer. Read More
(Alliance News) - A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the UK's Court of Appeal. Read More
(Alliance News) - AstraZeneca PLC on Monday said a breast cancer drug failed to significantly extend patients' lives, a second blow this month to hopes for the product. Read More
(Alliance News) - Stocks in London are to open higher on Monday, ahead of flash composite purchasing managers' index data from the US, the UK and mainland Europe. Read More
(Alliance News) - AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in the US. Read More
(Alliance News) - Stock prices in London went into Wednesday's afternoon on weaker footing, with trade tepid ahead of the evening's Federal Reserve decision, which is on a knife-edge. Read More
(Alliance News) - AstraZeneca PLC on Wednesday announced Fasenra has been approved in the US to treat adult patients with eosinophilic granulomatosis with polyangiitis, or EGPA. Read More
(Alliance News) - The FTSE 100 is called to open lower on Wednesday, as investors digest a UK inflation reading, and look ahead to a US interest rate decision later. Read More
(Alliance News) - AstraZeneca PLC on Monday said that Imfinzi plus Imjudo showed a clinically meaningful overall survival benefit for patients with a form of liver cancer. Read More
(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday reported "substantial clinical activity" for Enhertu in a recent clinical trial. Read More
(Alliance News) - Shares in London ended the week on the front foot, as markets priced in rising speculation that the Federal Reserve could yet deliver a bigger-than-expected rate cut next week. Read More
(Alliance News) - London's FTSE 100 held modest gains at midday on Friday as mining stock strength offset further falls for index heavyweight, AstraZeneca. Read More
(Alliance News) - London's FTSE 100 opened a touch higher on Friday, adding to its weekly gains, with gold miners among those in the green in early trade, though AstraZeneca fell after a downbeat broker assessment. Read More
